pirinixic acid has been researched along with Osteoarthritis, Knee in 2 studies
pirinixic acid: structure
Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clockaerts, S | 2 |
Bastiaansen-Jenniskens, YM | 2 |
Feijt, C | 2 |
Verhaar, JA | 2 |
Somville, J | 2 |
De Clerck, LS | 1 |
Van Osch, GJ | 2 |
De Clerck, L | 1 |
Zuurmond, AM | 1 |
Stojanovic-Susulic, V | 1 |
Kloppenburg, M | 1 |
2 other studies available for pirinixic acid and Osteoarthritis, Knee
Article | Year |
---|---|
Peroxisome proliferator activated receptor alpha activation decreases inflammatory and destructive responses in osteoarthritic cartilage.
Topics: Aggrecans; Cartilage, Articular; Cells, Cultured; Collagen Type II; Dinoprostone; Glycosaminoglycans | 2011 |
Cytokine production by infrapatellar fat pad can be stimulated by interleukin 1β and inhibited by peroxisome proliferator activated receptor α agonist.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Anticholesteremic Agents; Chemokine CCL2; Cyclooxygenase 2; | 2012 |